MicroRNA-204 Deficiency in Human Aortic Valves Elevates Valvular Osteogenic Activity

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Biochemistry

Background:

• Calcific aortic valve disease (CAVD) involves valvular calcification driven by aortic valve interstitial cells (AVICs).
• The mechanisms underlying the pro-osteogenic phenotype of AVICs in diseased valves are not fully understood.
• MicroRNA-204 (miR-204) is known to inhibit osteoblast differentiation.

Purpose of the Study:

• To investigate miR-204 expression in human aortic valves affected by CAVD.
• To determine the functional role of miR-204 in AVIC osteogenic activity relevant to CAVD.
• To explore the therapeutic potential of modulating miR-204 for CAVD.

Main Methods:

• In situ hybridization and PCR to assess miR-204 expression in diseased and normal valves/AVICs.
• In vitro experiments using miR-204 mimics and antagomirs in AVICs to evaluate effects on alkaline phosphatase (ALP) and calcium deposition.
• In vivo studies involving miR-204 antagomir administration in mouse aortic valves.
• Assessment of osteogenic markers Runx2 and Osx, and response to TGF-β1 stimulation.

Main Results:

• Diseased aortic valves and their AVICs exhibit significantly reduced miR-204 expression.
• Overexpression of miR-204 suppressed alkaline phosphatase (ALP) activity and calcium deposition in diseased AVICs.
• Inhibition of miR-204 in normal AVICs and mouse valves promoted osteogenic activity and calcification via Runx2 and Osx.
• miR-204 mimic counteracted the pro-osteogenic effects of TGF-β1 in normal AVICs.

Conclusions:

• miR-204 deficiency is a key factor contributing to the elevated osteogenic activity observed in CAVD.
• miR-204 can reverse the pro-osteogenic phenotype of AVICs and inhibit their response to stimuli.
• Modulating miR-204 levels presents a potential therapeutic avenue for preventing or treating valvular calcification in CAVD.